News

Stay up to date with insights, releases and more.

The Role of Mental Health in Dementia Prevention

The Influence of Social Determinants on Dementia Prevalence

Understanding Mild Cognitive Impairment (MCI) and Its Progression

Innovations in Non-Pharmacological Therapies for Dementia

The Impact of Cardiovascular Health on Dementia Risk

The Role of Physical Exercise in Preventing Cognitive Decline

The Connection Between Sleep Disorders and Alzheimer's Disease

How Can You Prevent Alzheimer’s Naturally?

February 28, 2025

What Are the First Signs of Early-Onset Alzheimer’s?

February 25, 2025

What Is the Difference Between Dementia and Alzheimer’s?

February 21, 2025

Can Stress Cause Dementia or Alzheimer’s?

February 18, 2025

What Are the 5 Warning Signs of Alzheimer’s Disease?

February 14, 2025

What a Typical Day Looks Like for Someone with Alzheimer’s

February 11, 2025

How Alzheimer’s Changes a Person Over Time

February 7, 2025

Why Does Alzheimer’s Get Worse at Certain Times of the Day?

February 4, 2025

Understanding the Impact of Alzheimer’s on Daily Life

January 30, 2025

The Stages of Alzheimer’s: What to Expect

September 6, 2024

Advancements in Alzheimer’s Diagnostics: The Role of the DISCERN™ Test

September 2, 2024

Benefits of the DISCERN™ Test in Clinical Practice

The Economic Impact of Early Alzheimer's Detection

Real Stories, Real Impact

Dr. Magdalena Traudt, MD

A Doctor's Commitment to Early Diagnosis

Clara's Unexpected Diagnosis

A Journey Towards Clarity

Learn More about discern™

Explore the Future of Alzheimer’s Diagnostics

Have questions or need assistance? We’re here to help!

Providing healthcare professionals with the necessary scientific data to identify Alzheimer’s Disease and distinguish it from other dementias - because being in doubt is simply not acceptable.

This test was developed, and its performance characteristics determined by NeuroDiagnostics Inc, dba Synaps Dx. It has not been cleared or approved by the U.S. Food and Drug Administration. NeuroDiagnostics, Inc. is regulated under the Clinical Laboratory Improvement Amendments (CLIA) as an accredited laboratory to perform high complexity clinical testing. The test is intended for patients with dementia. Test results should be interpreted in conjunction with other laboratory and clinical data available to the clinician. All rights reserved.